• About
  • Subscribe
  • Advertise
  • Contact
Thursday, January 22, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Alcon launches Systane Complete in Australia and New Zealand

by Staff Writer
March 6, 2022
in Dry eye, Local, News, Products, Therapies
Reading Time: 3 mins read
A A
Alcon Systane Complete

Upon instillation the HP-Guar and borate crosslink to form a viscoelastic meshwork.

Share on FacebookShare on Twitter

Alcon has expanded its range of preservative-free eye drops with the addition of Systane Complete Preservative-free. The lubricating eye drop combines the long-lasting formulation of Systane Complete with a multi-dose, preservative-Free bottle, the company announced.

According to Alcon, Systane Complete uses Systane’s Intelligent Delivery system of HP-Guar and borate in combination with nano-lipid technology to support all layers of the tear film and relieve the symptoms of all types of dry eye – aqueous deficient, evaporative and mixed dry eye.

“Upon instillation the HP-Guar and borate crosslink to form a viscoelastic meshwork,” the company stated.

“This meshwork forms a bandage over the ocular surface, preferentially binding to damaged areas of the cornea and increasing retention of the demulcents in the drop, for extended protection and lubrication.”3,4

Alcon said the nano-emulsion had been formulated with mineral oil and a patented anionic phospholipid delivered in nano-sized lipid droplets. The nano-size droplets faciliate migration to the top of the tear film to replenish the lipid layer and help stabilise the tear film.1,2,6

The bottle features patented PureFlow Technology, which is comprised of a one-way valve to ensure no contaminated liquid can be re-introduced into the container and a fine silicone membrane to filter returned air. The bottle has a low squeeze force and features a blue tip to aid targeting of the eye for ease of installation.5

This eye drop is suitable for those with mild-moderate dry eye* in any of the sub-categories (ADDE, EDE or mixed)1,2 and it provides relief of symptoms of dry eye for up to eight hours.

*recommendation based upon expected on-eye viscosity.

References

  1. Rangarajan, R and Ketelson, H. Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium. 1, s.l. : Mary Ann Liebert, Inc, 2019, Journal of Ocular Pharmacology and Therapeutics, Vol. 35.
  2. DOF – Nanoemulsion for MGD. s.l. : Available on request, 2013.
  3. Springs, C. Novel Ocular Lubricant Containing an Intelligent Delivery System: Details of Its Mechanism of Action. Dev Ophthalmol. Basel, Karger, 2010, vol 45, pp 139–147
  4. Alison Ng, et al. Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops. Clin Ophthalmol. 2018 Apr 10;12:695-700.
  5. Nemera Novelia Product Leaflet, 2015. Available: http://www.nemera.net/wp-content/uploads/2014/06/Brochure_Ophthalmic.pdf (Accessed 23-Jul-2021)
  6. Silverstein et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial Clin Ophthalmol 2020; 14: 3167-3177. Sponsored by Alcon

More reading

Alcon announces APAC leadership reshuffle

Alcon to acquire Hydrus Microstent MIGS device for AU$640 million

Alcon launches breakthrough Vivity IOL in Australia

Related Posts

A common Parkinson’s disease medication may reduce the risk of AMD progression. Image: Siam/stock.adobe.com

Parkinson’s drug may lower risk of AMD progression, study finds

by Staff Writer
January 22, 2026

A recent study suggests that levodopa, a common Parkinson’s disease medication, may reduce the risk of progression from early-stage age-related...

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

There are plenty of pathways to help optometrists and dispensers into practice ownership. Image: Fxquadro/stock.adobe.com.

Webinar to help dispensers, optometrists into ownership

by Staff Writer
January 21, 2026

Optical Dispensers Australia (ODA), Eyecare Plus, ProVision, Vision Connection and Eyebenefit are working together to guide entrepreneurs and open the...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited